The silent “G” : a case study in the production of “drugs” and “drug problems”

Moore, K ORCID: and Measham, F 2012, 'The silent “G” : a case study in the production of “drugs” and “drug problems”' , Contemporary Drug Problems, 39 (3) , pp. 565-590.

Full text not available from this repository. (Request a copy)


This article focuses on “G” in the United Kingdom (UK), G being the collective term for gamma-hydroxybutyrate (GHB) and gammabutyrolactone (GBL). Drawing on empirical data and taking a critical drug studies perspective, we use G as a case study in how drug cultures move through phases whereby a diffuse and contested network of emergent practices, agencies, and processes become progressively ordered into a more stable and conventional set of problems and actors, here G and the “G problem.” The production of former “legal high” G as a particular kind of drug in this network has shaped its relative neglect within UK research, policy, and practice as compared to mephedrone, another former legal high. Our case study supports the longstanding observation that researchers, policy makers and practitioners contribute to the performative and material constitution of “drugs” and “drug problems,” upon which we reflect in our conclusion.

Item Type: Article
Schools: Schools > School of Health and Society
Journal or Publication Title: Contemporary Drug Problems
Publisher: SAGE Publications
ISSN: 0091-4509
Depositing User: USIR Admin
Date Deposited: 11 Jan 2019 13:08
Last Modified: 27 Aug 2021 21:18

Actions (login required)

Edit record (repository staff only) Edit record (repository staff only)